Session Details
Poster Exhibition 1
Fri. Jul 11, 2025 9:00 AM - 6:00 PM JST
Fri. Jul 11, 2025 12:00 AM - 9:00 AM UTC
Fri. Jul 11, 2025 12:00 AM - 9:00 AM UTC
Room Ⅷ (Makuhari Messe Meeting Room 302)(Makuhari Messe Meeting Room 302)
[PE-001]Clinicopathological study of primary small bowel malignant tumors: A single institute experience in Taiwan
*PO JU HUANG1,3, YI HUA WU1,3, KEN SHENG CHENG1,2, JEN WEI CHOU1,2,3 (1. Center for Digestive Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan, 2. School of Medicine, China Medical University, Taichung, Taiwan, 3. Taiwan Association for the Study of Small Intestinal Diseases (TASSID))
[PE-002]Whole-exome sequencing for identifying three novel susceptible genetic loci in Korean patients with inflammatory bowel disease
*Dong Hwan Shin1, Mina Cho 2, Jongwook Yu1, Jae Hee Cheon1, Ju Han Kim2 (1. Department of Gastroenterology, Yonsei University College of Medicine, 2. Seoul National University Biomedical Informatics (SNUBI), Division of Biomedical Informatics, Seoul National University College of Medicine)
[PE-003]Effectiveness of adjunctive use of antibiotics in acute severe ulcerative colitis
*Hye Kyung Hyun1, Jihye Park2, Soo Jung Park2, Jae Jun Park2, Tae Il Kim2, Jae Hee Cheon2 (1. Yonsei University College of Medicine, Yongin Severance Hospital, 2. Yonsei University College of Medicine,Severance Hospital)
[PE-004]Re-bleeding risk associated with catheter angiography and colonoscopy following a positive computed tomography angiography in patients experiencing severe lower gastrointestinal bleeding
*Jihye Park1, Seo Yoon Choi1, Soo Jung Park1, Jae Jun Park1, Tae Il Kim1, Jae Hee Cheon1 (1. Yonsei College of Internal Medicine)
[PE-005]Transient elastography with controlled attenuation parameter for the evaluation of hepatic fibrosis in a prospective cohort of inflammatory bowel disease patients
*WON MOON1, Kwang Il Seo1, Hyun Joon Park1 (1. Department of Internal Medicine, Kosin University College of Medicine, Kosin University Gospel Hospital, Busan, Korea)
[PE-006]Difference in Immune Profiling According to the Metabolic Dysfunction-Associated Steatotic Liver Disease in Ulcerative Colitis Patients
*JAESEUNG SOH1, TaeHyung Kim2 (1. Hallym University Sacred Heart Hospital, 2. Korea University College of Medicine)
[PE-007]Clinical implication of nonalcoholic fatty liver disease in ulcerative colitis patients
*JAESEUNG SOH1, TaeHyung Kim2 (1. Hallym University Sacred Heart Hospital, 2. Korea University College of Medicine)
[PE-008]Short- and long-term outcome of endoscopic resection for serrated polyps in patients with ulcerative colitis
*Masafumi Nishio1,2, Reiko Kunisaki2, Yuki Koyo2, Yuki Suga2, Kazuki Kurimura2, Serina Haruyama2, Yoshinori Nakamori2, Tsuyoshi Ogashiwa2, Hideaki Kimura2, Kingo Hirasawa1, Shin Maeda3 (1. Division of endoscopy, Yokohama City University Medical Center, 2. Inflammatory Bowel Disease Center, Yokohama City University Medical Center, 3. Department of Gastroenterology , Yokohama City University)
[PE-009]Advanced therapy in patients with ulcerative colitis and malignant disease: A case study
*Tsutomu Masuda1,2, Naoki Inatsugi2, Syusaku Yoshikawa2, Seiji Terauci2, Hideki Uchida2, Takeshi Nakao2, MIzumi Inagaki2, Takashi Yokoo2, Takahumi Tani2, Kohei Okamoto2, Yusuke Shibata2 (1. Ikoma Gastroenteroproctorogy Clinic, 2. Dongo hospital Nara Digestive Proctorogy Center)
[PE-010]Inflammatory Bowel Disease Patients need Higher Opioid Analgesic for Intravenous Conscious Sedation for Colonoscopy.
*Young Sook Park1, Gyeol Seong1, Young Mi Jeon1, Joo Won Chung 1, Sang Bong Ahn1 (1. Eulji University , Nowon Eulji University Hospital , Dept of Gastroenterology)
[PE-011]Comparison of clinical characteristics of Montreal classification group A3 patients with Crohn’s disease in Korea: Results from the Prospective and Retrospective CONNECT Study,
*Jiyoung yoon1, You Sun kim1, Byong Duk Ye2, Jae Hee Cheon3, Jong Pil Im4, Joo Sung Kim4 (1. Kangdong Sacred Heart Hospital, 2. Asan Medical Center, University of Ulsan College of Medicine, 3. Yonsei University College of Medicine, 4. Seoul National University College of Medicine)
[PE-012]Segmental Mucosal Microbiome Variations Across Different Inflammation Extents in Ulcerative Colitis
*Jongbeom Shin1, Boram Cha1, JI Taek Hong1, Kwangwoo Nam2, Kye Sook Kwon1 (1. Inha university hospital, 2. Dankook University hospital)
[PE-013]Risk Factors of Extraintestinal Manifestations in IBD
*Hee Seok Moon1, Ju Seok Kim1, Yunho Jung2, Sang-Bum Kang3, Kwang woo Nam4, Sung Hyeok Ryou4, Jeong Eun Shin 4, Kyu Chan Huh5, Hoon Sup Koo 5, Dae Sung Kim 5 (1. Department of Internal Medicine, Chungnam National University School of Medicine, 2. Department of Internal Medicine, College of medicine, Soonchunhyang University, 3. Department of Internal Medicine, Daejeon St. Mary`s Hospital, The Catholic University , 4. Department of Internal Medicine, Dankook University Hospital, Dankook University College of Medicine, 5. Department of Internal Medicine, Konyang University College of medicine)
[PE-014]Impacts of Serum Microelements on Disease Activity in Patients with Inflammatory Bowel Disease on Asian Population-Based Study
*Tien-Yu Huang1,2,3, Chao-Feng Chang1,3, Yi-Chiao Cheng4,2, Chang-Hung Liao1,3, Puo-Hsien Le5,2,3 (1. Division of Gastroenterology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, 2. Taiwan Society of Inflammatory Bowel Disease, 3. Taiwan Association for the Study of Intestinal Diseases, 4. Division of Colon and Rectal Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, 5. Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Linkou Branch)
[PE-015]Prevalence and Association Between Antinuclear Antibodies and Inflammatory Bowel Disease in Taiwan
*Hsu-Heng Yen1, Yang-Yuan Chen1, Tsui-Chun Hsu1 (1. Changhua Christian Hospital)
[PE-016]Surveillance of Hepatitis B and C Serological Status in Inflammatory Bowel Disease Patients: A Single Hospital Data
*Yueh-An Lee1, Hsu-Heng Yen1 (1. Division of Gastroenterology, Changhua Christian Hospital)
[PE-017]Ulcerative Colitis with Pyoderma Gangrenosum
*Tsui-Chun Hsu1, Hsu-Heng Yen (1. Changhua Christian Hospital)
[PE-018]Treating Ulcerative Colitis Flare-Ups During Postpartum Lactation with Vedolizumab
*Tsui-Chun Hsu1, Hsu-Heng Yen1 (1. Changhua Christian Hospital)
[PE-019]A Case of Allergy to Upadacitinib in Ulcerative Colitis
*Akira Madarame1,2, Ryoya Kanda1, Makoto Arashiyama1 (1. Department of Gastroenterology and Hepatology, Niizashiki Central General Hospital, 2. Department of Gastroenterology and Hepatology, Tokyo Medical University Hospital)
[PE-020]Effect of Modified Traditional Jiangnan Diet (MTJD) in Patients with Crohn’s Disease: a Pilot, Open-label, Randomized Clinical Trial
*Xiao Xu Huang1, Qiao Yu2, Zhifang Zhong1, Shuyan Li 3, Yang Tang4, Wen Hu5, Yunpiao Hou1, Jiakai Luo2, Zexin Chen6, Yunxian Zhou7, Xiujun Liao4, Yan Chen2, Pianhong Zhang1 (1. Department of Nutrition, The Second Affiliated Hospital, Zhejiang University School of Medicine, 2. Department of Gastroenterology, The Second Affiliated Hospital, Zhejiang University School of Medicine, 3. Department of Nursing, The Second Affiliated Hospital, Zhejiang University School of Medicine, 4. Department of Colorectal Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, 5. Department of Gastroenterology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine) , 6. Department of Science and Research, The Second Affiliated Hospital, Zhejiang University School of Medicine, 7. School of Nursing, Zhejiang Chinese Medical University)
[PE-021]Ulcerative Colitis Disease Activity During Surveillance Endoscopy in a Single Medical Center
*Hsu-Heng Yen1, Yang-Yuan Chen1, Tsui-Chun Hsu1 (1. Changhua Christian Hospital)
[PE-022]Emergence of a novel macrophage population during intestinal inflammation and fibrosis
*Junya Tsunoda1,2, Ichiro Mizushima1, Yoshiaki Takada1, Yuya Hagihara1, Yuta Kaieda1, Shinya Sugimoto1, Toshiro Sato3, Yohei Mikami1, Takanori Kanai1 (1. Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, 2. Department of Surgery, Keio University School of Medicine, 3. Department of Integrative Medicine and Biochemistry, Keio University School of Medicine)
[PE-023]Case Report of Glucocorticoid Combined With Sequential Stages of Chinese Medicine Treatment on Severe Ulcerative Colitis
*Jing Ni1, Jingyi Shan1, Junren Yao1, Jiang Lin1 (1. Longhua Hospital, Shanghai University of Traditional Chinese Medicine)
[PE-024]Unveiling Mesenteric and Intestinal Changes in Crohn’s Disease: Insights into Fibrosis from Surgical Specimens
*Yehyun Park1, Yang Hee Joo1, Eun Mi Song1, A-Reum Choe1, Ju Ran Byeon1, Gyoung Tae Noh1, Ho Seung Kim1, Euno Choi1, Jieun Byun1, Jihye Park1, Yong-Ho Ahn1, Sung-Ae Jung1 (1. Ewha Womans University Seoul Hospital)
[PE-025]Real-world Experience With Janus Kinase Inhibitors (JAKis) In Patients With Inflammatory Bowel Disease (IBD) – A Multi-Centre Experience From Singapore
*Tian Yu Qiu1, Francis Teh2, Jonathan Koh3, Tze Tong Tey2, Huiyu Lin3, Shu Wen Tay1, Malcolm Teck Kiang Tan1, Ennaliza Salazar1 (1. Department of Gastroenterology and Hepatology, Singapore General Hospital, 2. Sengkang General Hospital, 3. Tan Tock Seng hospital)
[PE-026]Risk Factors and Awareness of Bone fragility in Inflammatory Bowel Disease in Taiwan: A Cross-Sectional Study
*Yao-Wei Kuo1,2, Chia-Jung Kuo1,2,3,4,6, Puo-Hsien Le1,2,3,4,6, Ming-Ling Chang1,2,4, Cheng-Yu Lin1,2,4,6, Chen-Ming Hsu1,2,4,6, Wei-Pin Lin1,2,4,6, Chun-Wei Chen1,2,4,6, Wey-Ran Lin1,2,4, Yu-Pin Ho1,2, Ming-Yao Su2,5,6, Cheng-Tang Chiu1,2,3,4,6 (1. Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Linkou 333423, Taiwan, 2. Chang Gung University, College of Medicine, Taoyuan 333001, Taiwan, 3. Chang Gung Microbiota Therapy Center, Taoyuan 333423, Taiwan., 4. Chang Gung Inflammatory Bowel Diseases Center, Linkou Chang Gung Memorial Hospital, Taoyuan 333423, Taiwan., 5. Department of Gastroenterology and Hepatology, New Taipei Municipal Tu Cheng Hospital (Built and Oper-ated by Change Gung Medical Foundation), New Taipei City 236017, Taiwan., 6. Taiwan Association for the Study of Intestinal Disease, Taoyuan 333423, Taiwan)
[PE-027]Aeromonas hydrophila Colitis Mimicking Ulcerative Colitis in an Adolescent Male
*Yoshiharu Yamaguchi1, Mayu Tomita1, Akihiro Nomura1, Takuya Takayama1, Takashi Tashiro1, Satoshi Ono1, Tomoya Sugiyama1, Kazunori Adachi1, Masahide Ebi1, Naotaka Ogasawara1, Makoto Sasaki1, Kunio Kasugai1 (1. Aichi Medical University Hospital)
[PE-028]Treat to Target Strategy In IBD: A Real World Multicentre Experience In Singapore
*Yi Yuan Tan1, Tze Tong Tey3, Kelvin Thia4, Zhi Hao Yan3, Tian Yu Qiu1, Justin Wen Hao Leong1, Sushmitha C1, Ian Yang Liew2, Huiyu Lin2, Thomson Chong Teik Lim1, Shu Wen Tay1, Malcolm Tan1, Ennaliza Salazar1 (1. Department of Gastroenterology and Hepatology, Singapore General Hospital, 2. Department of Gastroenterology and Hepatology, Tan Tock Seng Hospital, 3. Sengkang General Hospital, 4. Mount Elizabeth Hospital)
[PE-029]You will be forcibly logged out, if you leave this page for 60 minutes.
If you want to interrupt the abstract submission, click the "Save and Continue" button to save it.
Joo Hye Song1, *Jongbeom Shin3, Kwangwoo Nam2, Sung Min Kong4, Boram Cha3, JI Taek Hong3, Kye Sook Kwon3 (1. Konkuk University Medical Center, 2. Dankook University hospital, 3. Inha university hospital, 4. Samsung Changwon Hospital)
[PE-030]Safety of the Adjuvant Recombinant Herpes Zoster Vaccine in Crohn’s Disease and Ulcerative Colitis: A Real-World Study
*Dong Hyun Kim1, Ye Hyun park2, Sang-Bum Kang3, Kyeong Ok Kim4, Sang Hyoung Park5, Yoo Jin Lee6, Jun Lee7, Won Moon8, Soo Jung Park9, Soo-Young Na10, Eun Sun Kim11, Shin Ju Oh12, Seung Yong Shin13 (1. Chonnam National University Hospital and Medical School, 2. Ewha Womans University College of Medicine, 3. College of Medicine, Daejeon St. Mary’s Hospital, 4. Yeungnam University College of Medicine, 5. Asan Medical Center, University of Ulsan College of Medicine, 6. Keimyung University School of Medicine, 7. College of Medicine, Chosun University, 8. Kosin University College of Medicine, 9. Severance Hospital, Yonsei University College of Medicine, 10. Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 11. Korea University College of Medicine, 12. Kyung Hee University Hospital, Kyung Hee University College of Medicine, 13. Chung-Ang University College of Medicine)
[PE-031]Comparative Study on the Efficacy of Biologics with Dietary Intervention in Crohn's Disease: Evaluating the Impact of Crohn's Disease Exclusion Diet and partial Entral nutrition Combination with Biologics
*Hyun-Soo Kim1, Dong Hyun Kim1 (1. Chonnam Naitonal University Hospital)
[PE-032]Characterization of the phage of Japanese patients with ulcerative colitis
*Yoshihiro Yokota1, Takayuki Imai1, Ryo Mizuno1, Akinori Otsuki1, Masashi Ohno1, Atsushi Nishida1 (1. Department of Medicine, Shiga University of Medical Science)
[PE-033]Challenges in Accessing Biologics for IBD in Taiwan: A Study of NHI Reimbursement Rejections In a Medical Center
*Chih-Wen Huang1, Hsu-Heng Yen1 (1. Changhua Christian Hospital)
[PE-034]Barriers and Perceptions of Zoster Vaccination Among Patients with Inflammatory Bowel Disease: A Cross-Sectional Survey Study
*Yueh-An Lee1, Hsu-Heng Yen1, Jen-Wei Chou2 (1. Division of Gastroenterology, Changhua Christian Hospital, 2. Center for Digestive Medicine, Department of Internal Medicine, China Medical University Hospital)
[PE-035]High cholesterol diet promotes the development and progression of IBD-associated colorectal cancer by increasing the inflammatory cytokines and oxydized derivatives of cholesterol
*Hyung-Hoon Oh1, Chan-Muk Im1, Chae-June Lim1, Je-Seong Kim1, Young-Eun Joo1 (1. Chonnam National Univeristy Medical School)
[PE-036]The role of immunosuppressant agent in the era of non-anti-TNF biologics for inflammatory bowel disease
*Wei-Chen Lin1, Chen-Wang Chang1, Ching-Wei Chang1, Tzu-Chi Hsu2, Horng-Yuan Wang1 (1. Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan, 2. Division of Colon and Rectal Surgery, Mackay Memorial Hospital, Taipei, Taiwan)
[PE-037]Analysis of the intestinal microbiome using an endoscopic brush in Ulcerative colitis
*Bomee Lee Lee1, Yoontae Jeen1, Bora Keum1, Wonsuck Yoon1, Sanghyun Kim1, Hanjo Jeon1, Hoonjai Chun1 (1. College of Medicine, Korea University)
[PE-038]Oral and Gut Microbiome Analysis in Korean Patients with Crohn’s Disease
*Bomee Lee Lee1, Yoontae Jeen1, Bora Keum1, Sanghyun Kim1, Hanjo Jeon1, Hyuksoon Choi1, Hoonjai Chun1 (1. Division of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Anam Hospital, College of Medicine, Korea University)
[PE-039]Factors influencing the discontinuation of biologic therapies in patients with inflammatory bowel disease
*Arisa Fukuyama1,2, Akio Nakashima1,2, Motoyasu Miyazaki1,2, Masakatsu Fujiki1, Hideki Kakimoto1, Takashi Hisabe3, Osamu Imakyure1,2 (1. Department of Pharmacy, Fukuoka University Chikushi Hospital, 2. Department of Pharmaceutical and Health Care Management, Faculty of Pharmaceutical Sciences, Fukuoka University, 3. Department of Gastroenterology, Fukuoka University Chikushi Hospital)
[PE-040]A Retrospective Cross-sectional Study of Clinical Characteristics and Treatment Differences in Elderly and Adults onset Ulcerative Colitis disease
*Hailong Li1,2, Qiao Meng2, Ranran Zeng1, Xuesong Yang2, Xiangchun Lin1, Jun Li2, Shigang Ding2 (1. Peking University International Hospital, 2. Peking University Third Hospital)
[PE-041]Comparative Transcriptomic Analysis of Tonsil-derived and Adipose-derived Mesenchymal Stem Cells: Proliferation, Migration, and Anti-inflammatory Potential in Murine Colitis Model
*Eun Mi Song1, Yang Hee Joo1, Ju-Ran Byeon1, A Reum Choe1, Yehyun Park1, Sung-Eun Kim1, Sung-Ae Jung1 (1. Department of Internal medicine, Ewha Womans University College of Medicine)
[PE-042]DIFFERENTIAL EFFICACY OF ADVANCED THERAPIES BY DISEASE LOCATION IN CROHN’S DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
*Han Hee Lee1, Yuhong Yuan2, Vipul Jairath2,3, Siddharth Singh4,5 (1. Division of Gastroenterology, Department of Internal Medicine, Yeouido St. Mary's Hospital College of Medicine, The Catholic University of Korea, 2. Division of Gastroenterology, Western University, London, ON, Canada, 3. Department of Epidemiology and Biostatistics, Western University, London, ON, Canada, 4. Division of Gastroenterology, Department of Medicine, University of California San Diego, La Jolla, California, USA, 5. Division of Biomedical Informatics, Department of Medicine, University of California San Diego, La Jolla, California, USA)
[PE-043]A rare case of rapid growth large diffuse B-cell lymphoma in ulcerative colitis with long-term remission
*SHOMA KIKUKAWA1, SHINSAKU NAGAMATSU1, YUYA NISHIO1, YUYA MATSUO1, KYOHEI MATSUURA1, YUKI FUJIMOTO1, KEISUKE NAKANISHI1, HIDEKI MATSUO1, MASAKAZU UEJIMA1, KEI MORIYA1 (1. Nara Prefecture General Medical Center)
[PE-044]Safety and Adverse Events of the Adjuvanted Herpes Zoster Vaccine (Shingrix) in Inflammatory Bowel Disease Patients: A Comparison of Age Groups Under and Over 50 Years
*Sang-Bum Kang1, Dong Hyun Kim2, Ye Hyun Park3, Kyeong Ok Kim4, Sang Hyoung Park5, Yoo Jin Lee6, Jun Lee7, Won Moon8, Soo Jung Park9, Soo-Young Na10, Eun Sun Kim11, Shin Ju Oh12, Seung Yong Shin13 (1. Daejeon St. Mary’s Hospital, College of Medicine, 2. Chonnam Naitonal University Hospital, 3. Ewha Womans University College of Medicine, 4. Yeungnam University College of Medicine, 5. Asan Medical Center, University of Ulsan College of Medicine, 6. Keimyung University School of Medicine, 7. College of Medicine, Chosun University, 8. Kosin University College of Medicine, 9. Severance Hospital, Yonsei University College of Medicine, 10. Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 11. Korea University College of Medicine, 12. Kyung Hee University Hospital, Kyung Hee University College of Medicine, 13. Chung-Ang University College of Medicine)
[PE-045]Fecal Calprotectin as a Potential Biomarker for Depression: A Systematic Review and Meta-Analysis
*ZiRu Zhou1, Bing Ni Wei1, Fan Chen2, Hao Hao Zhu2, Qiang Zhan1, Jing Sun1 (1. Department of Gastroenterology, The Affiliated Wuxi People’s Hospital of Nanjing Medical University, Wuxi, Jiangsu, China, 2. Mental Health Center of Jiangnan University, Wuxi Central Rehabilitation Hospital, Wuxi, Jiangsu, China)
[PE-046]Thromboembolic Risk of Upadacitinib in Inflammatory Bowel Disease: A Real-World Pharmacovigilance Analysis of Timing, Subtypes, and High-Risk Populations
*Chen Pan1, Siying Zhu2, Ying Zhao1, Xiangli Cui1, Ye Zong2 (1. Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing , China, 2. Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Diseases, Beijing Digestive Disease Center, Beijing, China)
[PE-047]Temporal Changes of Gut Microbiota and Micro-RNAs according to Disease Activity in Chronic Colitis
*Chang Soo Eun1, A-Reum Lee1, Byung Wook Jung1, Jae Gon Lee1, Dong Soo Han1 (1. Hanyang University Guri Hospital, Guri, Korea)
[PE-048]Leucine-rich alpha-2 glycoprotein as a valuable biomarker for detecting small bowel lesions in Crohn’s disease
*RYO MIZUNO1, MASASHI OHNO1, YOSHIHIRO YOKOTA1, TAKAYUKI IMAI1, ATSUSHI NISHIDA1 (1. Shiga University of Medical Science,)
[PE-049]Comparison of Ustekinumab and Vedolizumab for Moderate to Severe Ulcerative Colitis Following Prior Failure of Biologics or Small Molecule Drugs
Hong, Seung Hong1, *Dong Hoon Baek1, Geun Am Song1 (1. Department of Internal Medicine, Pusan National University School of Medicine, Biomedical Research Institute, Pusan National University Hospital, Busan, Korea)
[PE-050]Factors associated with urgent consultation recommendations for patients with inflammatory bowel disease calling a telephone service about worsening symptoms: a secondary analysis
*Aki Kawakami1, Makoto Tanaka1, Kayoko Sakagami2, Hiroaki Ito2 (1. Institute of Science Tokyo, 2. Kinshukai Infusion clinic)
[PE-051]Clinical Usefulness of Fecal Calprotectin in Assessing Disease Activity and Mucosal Healing in Intestinal Behçet’s Disease
*Woojin Ahn1, Jihye Park1, Seoyoon Choi1, Soo Jung Park1, Jae Jun Park1, Tae Il Kim1, Jae Hee Cheon1 (1. Department of Internal Medicine, Institute of Gastroenterology, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea)
[PE-052]A National Survey and Analysis of Treatment Goals for Inflammatory Bowel Disease Among Gastroenterologists in China
*You Zhi lan1, jin li wen1, shen jun3, ran zhi hua1,2, cai xian bin2 (1. Zhoupu Hospital Affiliated to Shanghai Health Medical College,Shanghai , 2. Shantou University Medical College,shantou,Guangdong, 3. Department of Gastroenterology,Renji, Hospital,Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai,China)
[PE-053]Exacerbation of Previously Undetected Ulcerative Colitis in a Patient Undergoing Nivolumab for Metastatic Melanoma
*Hyung-Hoon Oh1, Chan-Muk Im1, Chae-June Lim1, Je-Seong Kim1, Young-Eun Joo1 (1. Chonnam National Univeristy Medical School)
[PE-054]Incidence of Hepatitis A and Hepatitis C in Patients with Inflammatory Bowel Disease in Korea
*Jinhwa Park1, Sang Hyoung Park2 (1. Hanyang University Hospital, 2. Asan Medical Center)
[PE-055]Upadacitinib for the Treatment of Ulcerative Colitis: A Single-Center Study in North China
*Yaxin Qi1, Xin Xu1, Hailong Cao1 (1. Tianjin Medical University General Hospital Department of Gastroenterology and Hepatology)
[PE-056]Perceptions and Clinical Practices Regarding the Interrelation of Inflammatory Bowel Disease and Metabolic Disorders: An International Survey Study
*Yehyun Park1, Shu-Chen Wei2, Won Moon3, Katsuyoshi Matsuoka4, Soo Young Na5 (1. Ewha Womans University Seoul Hospital, 2. National Taiwan University Hospital, 3. Kosin University College of Medicine, 4. Toho University Sakura Medical Center, 5. Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea)
[PE-057]Clinical Impact of Withholding Oral Intake in Acute Severe Ulcerative Colitis: A Single-Center Retrospective Study
*Nobuaki Shu1, Jun Kato1, Yuki Ohta1, Makoto Furuya1, Ryosuke Horio1, Tsubasa Ishikawa1, Tatsuya Kaneko1, Takashi Taida1, Kenichiro Okimoto1, Tomoaki Matsumura1 (1. Chiba University, Graduate School of Medicine Department of Gastroenterology)
[PE-058]Evaluating Outcomes Based on Endoscopic and Histological Inflammatory Activity in Patients with Ulcerative Colitis
*ChengLu Lin1, Kuan-Chih Chen1, Jiann-Ming Wu2, Kuo-Hsin Chen2, Tzong-Hsi Lee1, Chen-Shuan Chung1 (1. Division of Gastroenterology and Hepatology, Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan, 2. Department of Surgery, Far Eastern Memorial Hospital, New Taipei City, Taiwan)
[PE-059]Guselkumab efficacy and safety in East Asian participants with moderate to severely active Crohn’s disease: Subgroup analysis of the GALAXI-2 and GALAXI-3 Phase 3 studies
*Hiroshi Nakase1, Baili Chen2, Qian Cao3, Katsuyoshi Matsuoka4, Tadakazu Hisamatsu5, Dong Il Park6, Brian Wahking7, Wai Chun Yiu8, Jianmin Zhuo9, Minhu Chen2 (1. Sapporo Medical University School of Medicine, Sapporo, Japan, 2. The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China, 3. Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China, 4. Toho University Sakura Medical Center, Chiba, Japan, 5. Kyorin University School of Medicine, Tokyo, Japan, 6. Kangbuk Samsung Hospital, Sungkyunkwan University, Seoul, Republic of Korea, 7. Janssen Asia Pacific, Singapore , 8. Janssen Research & Development, LLC, Spring House, PA, USA, 9. Janssen China R&D, Shanghai, China)
[PE-060]Efficacy and safety of subcutaneous guselkumab in East Asian participants with moderately to severely active Crohn’s disease: Subgroup analysis of the Phase 3 GRAVITI study
Wenjia Liu1, Hong Guo2, Tae Oh Kim3, *Ken Takeuchi4, Tadakazu Hisamatsu5, Jennifer Fable6, Mobolaji Olurinde6, Brian Wahking7, Jianmin Zhuo8, Qian Cao9 (1. The Second People’s Hospital of Changzhou, the Third Affiliated Hospital of Nanjing Medical University, Changzhou, 213003, China, 2. Chongqing General Hospital, Chongqing University, Chongqing, 400014, China, 3. Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea, 4. Director of Gastroenterology, Manager of IBD Centre, Tsujinaka Hospital Kashiwanoha, 146-6 Kashiwanoha Campus, 178-2 Wakashiba, Kashiwa City, Chiba 277-0871, Japan, 5. Department of Gastroenterology and Hepatology, Kyorin University School of Medicine, Tokyo, Japan, 6. Janssen Research & Development, LLC, Spring House, PA, USA, 7. Janssen Asia Pacific, Singapore , 8. Janssen China R&D, Shanghai, China, 9. Sir Run Run Shaw Hospital Affiliated with School of Medicine, Zhejiang University, Hangzhou, China)
[PE-061]Guselkumab efficacy and safety in East Asian participants with moderate to severely active ulcerative colitis: Subgroup analysis of the Phase 2b/3 QUASAR induction and maintenance studies
Baili Chen1, Byong Duk Ye2, Qian Cao3, Fumihito Hirai4, *Masayuki Saruta5, Minhu Chen1, Susan Pelak6, Nicole Shipitofsky6, Brian Wahking7, Jianmin Zhou8, Tadakazu Hisamatsu9 (1. The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China, 2. University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea, 3. Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China, 4. Fukuoka University Hospital, Fukuoka, Japan, 5. The Jikei University School of Medicine, Tokyo, Japan, 6. Janssen Research & Development, LLC, Spring House, PA, USA, 7. Janssen Asia Pacific, Singapore , 8. Janssen China R&D, Shanghai, China, 9. Kyorin University School of Medicine, Tokyo, Japan)
[PE-062]The biologics containing citrate deteriorate the willingness to continue treatment
*Soh Okano1, Akane Suda2, Takanori Nishiguchi1, Ryo Okubo1, Dai Yamazaki1, Tsubasa Tateishi1, Akira Sonoda1, Shiho Iwamoto1, Masayuki Fukata1, Minako Sako1 (1. Tokyo Yamate Medical Centre- Japan Community Healthcare Organization, Centre for Inflammatory Bowel disease- Division of Gastroenterology- Department of Internal Medicine, 2. Tokyo Yamate Medical Centre- Japan Community Healthcare Organization, Centre for Inflammatory Bowel disease- Nursing Division)
[PE-063]The Clinical Features of Obese Crohn’s disease in Patients
*Hongsub Lee1 (1. INJE UNIVERSITY BUSAN PAIK HOSPITAL)
[PE-064]Co-Infection of Clostridium difficile and Cytomegalovirus in First Presentation of Crohn's Colitis in an Elderly Patient
*Jonathan Koh1, Huiyu Lin1, Wee Chian Lim1, Raymong Liang1 (1. Tan Tock Seng Hospital)
[PE-065]Tofacitinib, rescue therapy for Infliximab-experienced patients with acute severe ulcerative colitis: A single centre experience
*Jonathan Koh1, Huiyu Lin1, Wee Chian Lim1, Liang Raymond1 (1. Tan Tock Seng Hospital)
[PE-066]Comparative Drug Survival of Anti-TNF Agents and Vedolizumab in Inflammatory Bowel Disease: A Single-Center Experience in Taiwan
*Chih-Wen Huang1, Hsu-Heng Yen1 (1. Changhua Christian Hospital)
[PE-067]CEPT1 Promote the Development of Mesenteric Adipose Tissue Fibrosis by Inhibiting Phosphatidylethanolamine Formation in DPP4+CCL2+ Mesenchymal Stem Cells
*Anqi Yu1, Fengfei Wu1, Lan Bai1 (1. Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, China.)
[PE-068]Current Status of Medical Care for Elderly Patients with Ulcerative Colitis at Our Hospital
*Ryo Karashima1, Takahito Toba1, Moeko Komatsu1, Aya Hojo1, Ai Fujimoto1, Takahisa Matsuda1 (1. Division of Gastroenterology and Hepatology, Department of Internal Medicine, Toho University, Omori Medical Center)
[PE-069]Changes in serum bile acid composition in patients with inflammatory bowel disease
*SU-MI LEE1, Seon-Young Park1, Dong-Hyen Kim1, Hyun Soo Kim1 (1. Department of internal Medicine, Chonnam National University Medical School, Gwangju, South Korea)
[PE-070]The Association between serum zinc levels and tight junction proteins in the intestinal mucosal epithelium in patients with inflammatory bowel disease.
*Asako Nomura1, Takehiko Katsurada1, Syo Tanaka1, Keiya Aoyama1, Naoya Sakamoto1 (1. Hokkaido University Hospital, Department of Gastroenterology and Hepatology)
[PE-071]Optimal timing and predictors of treatment response to intravenous corticosteroids therapy in hospitalized patients with ulcerative colitis
*Ryota Ogihara1, Minoru Matsuura1, Haruka Komatsu1, Takeshi Fujima1, Haruka Wada1, Noritaka Hibi1, Hiromu Morikubo1, Tatsuya Mistui1, Daisuke Saito1, Mari Hayashida1, Jun Miyoshi1, Teppei Omori1, Tadakazu Hisamatsu1 (1. Department of Gastroenterology, Kyorin University School of Medicine)
[PE-072]The impact of extraintestinal manifestations on disease courses in newly diagnosed patients with inflammatory bowel diseases
*Takeshi Fujima1, Minoru Matsuura1, Hiromu Morikubo1, Haruka Komatsu1, Haruka Wada1, Ryouta Ogihara1, Noriaki Oguri1, Noritaka Hibi1, Tatsuya Mitsui1, Daisuke Saito1, Mari Hayashida1, Jyun Miyoshi1, Teppei Omori1, Tadakazu Hisamatsu1 (1. Department of Gastroenterology,Kyorin University School of Medicine)
[PE-073]Seasonal variation in Crohn’s disease relapse: An ad-hoc analysis of a cohort of patients maintaining remission on receiving biologics
*Makoto Tanaka1, Kayoko Sakagami2, Hikaru Sakagami Mizuno2,3, Hiroaki Ito2 (1. Institute of Science Tokyo, 2. Kinshukai Infusion Clinic, 3. Kansai Medical University)
[PE-074]Evaluation of clinical activity index and biomarkers in predicting therapeutic efficacy of IL-12/23 inhibitors in patients with moderate to severe ulcerative colitis
*Kazuya Miyaguchi1, Yoshikazu Tsuzuki1, Hiroyuki Imaeda1 (1. Department of Gastroenterology, Saitama Medical University)
[PE-075]Long-Term Health Outcomes in Offspring of Women with Inflammatory Bowel Disease: A Nationwide Study
*Ja Seol Koo1, Dongwoo Kim1, Geum Joon Cho2, Young Mi Jung2 (1. Department of Gastroenterology, Korea Univ. College of Medicine Ansan Hospital, 2. Department of Obstetrics and Gynecology, Korea Univ. College of Medicine Guro Hospital)
[PE-076]A Real-World Adverse Events in Patients with Inflammatory Bowel Disease Treated with Advanced Therapies: A Nationwide Population-based Cohort Study in South Korea
*Jae Myung Cha1, Seon Hwa Lee2, Jae Kyung Shin3 (1. Kyung Hee University Hospital at Gangdong, 2. Korea University Guro Hospital, 3. Jeju 365 Plus Medical Center)
[PE-077]FIVE-YEAR CLINICAL OUTCOMES AND DISEASE COURSE OF NEWLY-DIAGNOSED MODERATE-TO-SEVERE ULCERATIVE COLITIS: A PROSPECTIVE NATIONWIDE MULTICENTER MOSAIK COHORT STUDY IN KOREA
*Byong Duk Ye2, Hyo Jong Kim1, Dong Il Park3, Young Sook Park4, Kang-Moon Lee5, Jong PIl Im6, Sung-Ae Jung7, Yoon Tae Jeen8, Jae Myung Cha9, Jae Hee Cheon10, Sung Noh Hong11, Youngdoe Kim12, Jong Min Choi12, Young Ja Lee Lee12, Chang Kyun Lee1 (1. Kyung Hee University Hospital, Kyung Hee University College of Medicine, Seoul, Korea, 2. Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, 3. Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea, 4. Nowon Eulji Hospital, Eulji University School of Medicine, Seoul, Korea, 5. St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea College of Medicine, Suwon, Korea, 6. Seoul National University College of Medicine, Seoul, Korea, 7. Ewha Womans University College of Medicine, Seoul, Korea, 8. Korea University, Anam Hospital, Korea University College of Medicine, Seoul, Korea, 9. Kyung Hee University Hospital at Gangdong, Kyung Hee University College of Medicine, Seoul, Korea, 10. Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, 11. Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, 12. Medical Affairs, Johnson & Johnson, Seoul, Korea)
[PE-078]Etiology and Differential Diagnosis of Terminal Ileum Lesions with Symptoms: A Retrospective Study of 224 Patients
*Woo Jin Kim1, Cheol Woong Choi1, Su Bum Park1, Su Jin Kim1, Jin Ook Jang1, Cheol Min Lee1, Su Bin Ssyn1 (1. Pusan National University Yangsan Hospital)
[PE-079]Pregnancy and Neonatal Outcomes After Fetal Exposure to Thiopurines Among Asian Women With Inflammatory Bowel Disease
*Mizuki Tatsuno1,2, Reiko Kunisaki1,2, Kazuki Kurimura1,2, Risa Onizawa1, Yuto Tsuru1, Yurika Nishikawa1, Yuki Suga1,2, Yuki Koyo1,2, Serina Haruyama1,2, Katsuki Yaguchi1,2, Yoshinori Nakamori1,2, Masafumi Nishio3, Tsuyoshi Ogashiwa1,2, Ayako Fujii1,2, Kota Imanishi1, Kenichiro Toritani1, Hideaki Kimura1, Shunsuke Asami1, Soichiro Obata4, Shigeru Aoki4, Shin Maeda2 (1. Inflammatory Bowel Disease Center, Yokohama City University Medical Center, 2. Department of Gastroenterology, Yokohama City University, Graduate School of Medicine, 3. Gastroenterological Center, Yokohama City University Medical Center, 4. Perinatal Center for Maternity and Neonates, Yokohama City University Medical Center)
[PE-080]Clinical Features and Treatment in Korean Patients with Gastrointestinal Behçet's Disease: A Retrospective Study of 327 Patients
*Su Bum Park1, Cheol Woong Choi1, Su Jin Kim1, Jin Ook Jang1, Woo Jin Kim1, Cheol Min Lee1, Su Bin Ssyn1 (1. Pusan National University Yangsan Hospital)
[PE-081]RESULTS OF THE SURGICAL TREATMENT OF ULCERATIVE COLITIS
*Erdene Bat-ulzii1 (1. The First Central Hospital of Mongolia)
[PE-082]Comparison of the prevalence and characteristics of biliary diseases in ulcerative colitis and Crohn’s disease.
*HYUNJOON PARK1, Won Moon1, Kwang Il Seo1 (1. Kosin University College of Medicine)
[PE-083]Therapeutic drug monitoring and efficacy evaluation of vedolizumab in patients with inflammatory bowel disease
*Mengxin Zhu1, qinhua Xi1 (1. the First Affiliated Hospital of Suzhou University)
[PE-084]Deep Learning Model Utilizing Stool Images to Differentiate Ulcerative Colitis from Irritable Bowel Syndrome and Healthy Controls
*Eun Soo Kim1, Hyun Seok Lee1, Sung Kook Kim1, Kyeong Ok Kim2, Byung Ik Jang2, Yoo Jin Lee3, Yun Jin Chung1, Hyeong Ho Jo4, Eun Young Kim4 (1. Kyungpook National University School of Medicine, 2. Yeungnam University College of Medicine, 3. Keimyung University School of Medicine, 4. Daegu Catholic University School of Medicine)
[PE-085]A Decade-Long Follow-up Study of Korean IBD Patients: Differences by Age at Diagnosis
*Subum Park1, Jinwook Jang1, Yong Eun Park2, Sang-Bum Kang3, Yehyun Park4, Daesung Kim5 (1. Pusan National University School of Medicine and Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, 2. Inje University School of Medicine, Haeundae Paik Hospital, Busan, Republic of Korea, 3. Daejeon St. Mary's Hospital, College of Medicine, the Catholic University of Korea, 4. Ewha Womans University Seoul Hospital, Seoul, Korea, 5. Konyang University College of Medicine, Daejeon, Republic of Korea)
[PE-086]Efficacy of upadacitinib to treat acute severe ulcerative colitis
*Yoshihiro Akita1, Toshiyuki Sakurai1, Aiko Kawamura1, Chiaki Sakayori1, Moe Komori1, Itsuka Kikuchi1, Naoki Shibuya1, Takahiko Toyonaga1, Tomohiro Kato1,2, Masayuki Saruta1 (1. Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, 2. Center for Preventive Medicine, The Jikei University School of Medicine)
[PE-087]Considering Longitudinal Changes and Patient Heterogeneity Improves Gut Microbiome Signatures for Predicting Adalimumab Efficacy in UC
*Seung Yong Shin1, Yeonjae Jung2, Hyun-Seok Oh2, Jung Min Moon1, Minjun Kim1, Chang Hwan Choi1 (1. Chung-Ang University, College of Medicine, Department of Internal Medicine, Seoul, South Korea, 2. CJ Bioscience, Inc. Seoul, South Korea)
[PE-088]Paradoxical onset of vasculitic diseases in patients with ulcerative colitis(UC) treated with anti-tumor necrosis factor(TNF)-α antibodies
*Yoshinori Nakamori1,2, Reiko Kunisaki1,2, Katsuki Yaguchi1,2, Yusuke Matsune1, Yuki Suga1,2, Yuki Koyo1,2, Kazuki Kurimura1,2, Serina Haruyama1,2, Shotaro Umezawa1,2, Tsuyoshi Ogashiwa1,2, Tomohiko Sasaki1, Ayako Fujii1,2, Kota Imanishi1, Kenichiro Toritani1, Hideaki Kimura1, Shin Maeda1,2 (1. Inflammatory Bowel Disease Center, Yokohama City University Medical Center, 2. Department of Gastroenterology, Yokohama City University, Graduate School of Medicine)
[PE-089]CHARACTERIZATION OF PHARMACOKINETICS OF GUSELKUMAB IN CHINESE CROHN’S DISEASE PATIENTS: GALAXI 2 AND 3 SUBGROUP ANALYSIS
*Baili Chen3, Zhongqi Dong1, Jingyun Li1, Tae Eun Yang1, Omoniyi J Adedokun1, Xuan Guo1, Kefira Ke2, Ting Zhao1, Minhu Chen3 (1. Johnson & Johnson, 2. IQVIA RSD (SHANGHAI) CO.LTD, 3. THE FIRST AFFILIATED HOSPITAL-SUN YAT-SEN UNIVERSITY)
[PE-090]EFFICACY OF GUSELKUMAB IN CHINESE PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE ACCORDING TO CLINICAL RESPONSE AT INDUCTION: SUBGROUP ANALYSIS OF THE PHASE 3 GALAXI 2 AND 3 STUDIES
Baili Chen2, *Qian Cao3, Jie Zhang4, Xiang Gao5, Yan Zhang6, Lan Rong7, Xuan Guo1, Wai Chun Yiu1, Kefira Ke8, Kitty Yuen Yi Wan1, Ting Zhao1, Minhu Chen2 (1. Johnson & Johnson, 2. The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 3. Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, 4. The Second Xiangya Hospital of Central South University, 5. The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, 6. West China Hospital, Sichuan University, 7. Huashan Hospital Affiliated with Fudan University, 8. IQVIA RSD (Shanghai) Co. Ltd)
[PE-091]EFFECT OF GUSELKUMAB VERSUS USTEKINUMAB ON BIOMARKERS IN CHINESE PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: SUBGROUP ANALYSIS OF THE RANDOMIZED, DOUBLE-BLIND, PHASE 3 GALAXI 2 AND 3 STUDIES
Baili Chen2, *Xiang Gao3, Jie Zhang4, Qian Cao5, Yan Zhang6, Yan Chen7, Xuan Guo1, Scott Pina1, Jiajia Lu1, Wilbert van Duijnhoven1, Ting Zhao1, Minhu Chen2 (1. Johnson & Johnson, 2. The First Affiliated Hospital of Sun Yat-sen University, 3. The Sixth Affiliated Hospital of Sun Yat-sen University, 4. The Second Xiangya Hospital of Central South University, 5. Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, 6. West China Hospital, Sichuan University, 7. The Second Affiliated Hospital of Zhejiang University School of Medicine)
[PE-092]EFFICACY OF GUSELKUMAB VERSUS PLACEBO BASED ON PRIOR EXPOSURE TO BIOLOGIC THERAPY IN CHINESE PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: SUBGROUP ANALYSIS OF GALAXI 2 and 3 STUDIES
Baili Chen2, Jie Zhang3, Qian Cao4, Xiang Gao5, *Yan Zhang6, Yan Chen7, Xuan Guo1, Leonard Salese1, Kefira Ke1,8, Kitty Yeun Yi Wan1, Ting Zhao1, Minhu Chen2 (1. Johnson & Johnson, 2. The First Affiliated Hospital of Sun Yat-sen University, 3. The Second Xiangya Hospital of Central South University, 4. Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, 5. The Sixth Affiliated Hospital of Sun Yat-sen University, 6. West China Hospital, Sichuan University, 7. The Second Affiliated Hospital of Zhejiang University School of Medicine, 8. IQVIA RSD (Shanghai) Co. Ltd)
[PE-093]Histologic and Combined Histologic and Endoscopic Outcomes After Guselkumab Maintenance Therapy in Chinese Patients With Moderately to Severely Active Ulcerative Colitis: Subgroup Analysis of the Phase 3 QUASAR Maintenance Study
Baili Chen1, Qian Cao2, *Yufang Wang3, Xuan Guo4, Shadi Yarandi5, Jiajia Lu6, Ye Miao5, Han GAO4, Minhu Chen1 (1. The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China, 2. Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China, 3. West China Hospital of Sichuan University, Chengdu, China, 4. Johnson & Johnson, Beijing, China, 5. Johnson & Johnson, Spring House, PA, USA, 6. Johnson & Johnson, Shanghai, China.)
[PE-094]Clinical profile of adverse events caused by immunomodulator in ulcerative colitis
*Takeshi Sugaya1, Shunsuke Kojimahara1, Mimari Kanazawa1, Satoshi Masuyama1, Yuka Yamazaki1, Takanao Tanaka1, Shoko Watanabe1, Keiichi Tominaga1, Atsushi Irisawa1 (1. Department of Gastroenterology, Dokkyo Medical University School of Medicine)
[PE-095]Structural and Functional Characteristics of Oral and Gut Microbiome of Perianal Fistulizing Crohn's Disease Patients
*Yuan Wang1, Xinmei Zhao1 (1. Nanfang Hospital, Southern Medical University, Guangzhou, China)
[PE-096]Correlation Between Ultrasonographic Response and Ustekinumab Drug Levels in Crohn’s disease
*Jiahua Zhou1, Xinmei Zhao1 (1. Nanfang Hospital, Southern Medical University, Guangzhou, China)
[PE-097]Longitudinal analysis of changes in gut microbiota and microRNA expression between active and remission phases in patients with ulcerative colitis
*Jae Gon Lee1, A-Reum Lee1, Byung Wook Jung1, Chang Soo Eun1, Dong Soo Han1 (1. Hanyang University Guri Hospital)
[PE-098]Correlations between the Simple Endoscopic Score for Crohn’s Disease and fecal calprotectin in pediatric patients with Crohn’s disease
*Byung Ho CHOE1, Yiyoung Kwon, Seo Hee Kim, Yoo Min Lee, Eun Sil Kim, Eun Hye Lee , Sujin Choi1, Ben Kang1 (1. Kyungpook National University)
[PE-099]Treatment Experience of Patients with Inflammatory Bowel Disease Using Biologic Agents/Janus Kinase Inhibitors
*Rino Kaizu1,2, Natsuko Seto2, Kayoko Sakagami1, Hiroaki Ito1 (1. Kinshukai Infusion Clinic , 2. Graduate Scholl of nursing , Kansai Medical University)
[PE-100]α-Linolenic Acid Metabolism as a Shared Pathway in Inflammatory Bowel Disease and Depression: Insights from Bioinformatic Analysis
*ZiRu Zhou1, Qiang Zhan1, Jing Sun1 (1. Department of Gastroenterology, The Affiliated Wuxi People’s Hospital of Nanjing Medical University)
[PE-101]A rare case of tuberous pericarditis in a patient treated with advanced therapy for Crohn’s disease and ankylosing spondylitis
*Kwangwoo Nam1, Jongbeom Shin2 (1. Dankook University Hospital, 2. Inha University Hospital)
[PE-102]Porphyromonas gingivalis aggravates Inflammatory bowel disease via outer membrane vesicles
*Yuzheng Zhao1, Congyi Yang1, Jingyi Chen1, Jvshan Wu1, Yalan Xu1, Huan Liu1, Ning Chen1 (1. Department of Gastroenterology, Peking University People’s Hospital, Beijing 100044, China)
[PE-103]Periodontitis exacerbates colitis via oral pathogen-induced epithelial extracellular vesicles
*Yuzheng Zhao1, Congyi Yang1, Jingyi Chen1, Jvshan Wu1, Yalan Xu1, Huan Liu1, Ning Chen1 (1. Department of Gastroenterology, Peking University People’s Hospital, Beijing 100044, China)
[PE-104]Factors associated with incomplete patency of capsule endoscopy in postoperative Crohn's disease patients: a sub-analysis of the J-PROSPECT study.
*Teppei Omori1,2, Motohiro Esaki3, Kenji Watanabe4, Shintaro Sagami5, Teruyuki Takeda6, Hironobu Takedomi3, Junji Umeno7, Takehiro Torisu7, Shojiro Yamamoto8, Mikihiro Fujiya9, Hisashi Shiga10, Mari Hayashida11, Fumikazu Koyama12, Shuji Kanmura13, Katsuyoshi Matsuoka14, Taku Kobayashi5, Masakazu Nagahori15, Ken Takeuchi16, Hiroshi Nakase17, Fumihito Hirai18, Takayuki Matsumoto19, Tadakazu Hisamatsu11 (1. Department of Gastroenterology and Hepatology, Kyorin University School of Medicine Suginami Hospital., 2. Institute of Gastroenterology, Tokyo Women's Medical University, 3. Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, Saga University, 4. Department of Internal Medicine for Inflammatory Bowel Disease, Toyama University, Toyama, 5. Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital, 6. IBD Center, Fukuoka University Chikushi Hospital, 7. Department of Medicine and Clinical Science, Graduate School of Medical Science, Kyushu University, 8. Division of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, 9. Gastroenterology and Endoscopy, Division of Metabolism and Biosystemic Science, Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University, 10. Division of Gastroenterology, Tohoku University Graduate School of Medicine, 11. Department of Gastroenterology and Hepatology, Kyorin University School of Medicine, 12. Department of Surgery, Nara Medical University, 13. Digestive and Lifestyle Diseases, Department of Human and Environmental Sciences, Kagoshima University Graduate School of Medical and Dental Sciences, 14. Division of Gastroenterology and Hepatology, Department of Internal Medicine, Toho University Sakura Medical Center., 15. Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, 16. Department of Gastroenterology, Tsujinaka Hospital Kashiwano-Ha, 17. Department of Gastroenterology and Hepatology, Sapporo Medical University School of Medicine, 18. Department of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, 19. Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Iwate Medical University)
[PE-105]Guselkumab efficacy and safety in East Asian participants with moderate to severely active ulcerative colitis: Subgroup analysis of the Phase 3 ASTRO subcutaneous induction and maintenance studies
Shigang Ding1, Naizhong Hu2, Xiaodi Wang3, Reiko Kunisaki4, *Ken Takeuchi5, Tae Oh Kim6, Horng-Yuan Wang7, Yelina Alvarez8, Keira Herr9, Jianmin Zhuo10, Tadakazu Hisamatsu11 (1. Department of Gastroenterology, Peking University Third Hospital, Beijing, China, 2. Department of Gastroenterology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China, 3. Department of Gastroenterology, China Japan Friendship Hospital, Beijing, China, 4. Inflammatory Bowel Disease Center, Yokohama City University Medical Center, Yokohama, Japan, 5. Department of Gastroenterology, IBD Centre, Tsujinaka Hospital Kashiwanoha, Kashiwa, Chiba, Japan, 6. Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea, 7. Division of Gastroenterology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan, 8. Johnson & Johnson, Spring House, PA, USA, 9. Johnson & Johnson, Singapore, Singapore, 10. Johnson & Johnson, Shanghai, China, 11. Department of Gastroenterology and Hepatology, Kyorin University School of Medicine, Tokyo, Japan)
[PE-106]Evaluating the Impact of a Nurse-led Telephone Advice Service on IBD Patient Care at Tan Tock Seng Hospital
*Yalan Hu1, Jacqueline Weiqian Lin1, Huiyu Lin2, Raymond Fueng Hin Liang2, Wee Chian Lim2 (1. Department of Nursing, Tan Tock Seng Hospital, Singapore, 2. Department of Gastroenterology & Hepatology, Tan Tock Seng Hospital, Singapore)
[PE-107]Real-World Efficacy and Safety of Filgotinib in Elderly and Elderly-Onset Ulcerative Colitis: A Retrospective Study
*Masatsugu Sato1, Ken Takeuchi2, Shiho Fujita1, Makoto Furuya2, Yukihiro Hamahata3 (1. Pharmacy Department, Tsujinaka Hospital Kashiwanoha, 2. Department of Gastroenterology, IBD Center, Tsujinaka Hospital Kashiwanoha, 3. Department of Colorectal and Proctological Surgery, IBD Center, Tsujinaka Hospital Kashiwanoha)
[PE-108]Dietary Acceptance of Crohn’s Disease Exclusion Diet (CDED) Among IBD Patients In Malaysia: A Qualitative Study
*Nazihah Wafi1, Khoo Xin Hui2, Lee Yew Kong1, Ng Ai Kah1, Ida Normiha Hilmi1 (1. University of Malaya, 2. Universiti Malaya Medical Centre)
[PE-109]Neonatal Fc Receptor-Mediated Mechanisms in IBD Pathophysiology and Therapeutic Applications
*Xin Hong1, Keiko Maeda1, Hiroki Kawashima1 (1. Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine)
[PE-110]Real-world evidence of recapturing clinical remission with subcutaneous infliximab after switching from intravenous therapy in patients with ulcerative colitis: A 2-year multicenter prospective study in Korea
*Kyuwon Kim1, Sung Noh Hong2, Sang-Bum Kang3, Kang-Moon Lee4, Ja Seol Koo5, Yunho Jung6, Hyuk Yoon7, Beom Jae Lee8, Hyun Seok Lee9, Yoo Jin Lee10, Yun Jeong Lim11, Jun Lee12, Chang Kyun Lee13, Seung Yong Shin14, Jung Min Moon14, Jeongkuk Seo1, Chang Hwan Choi1 (1. Chung-Ang University Hospital, 2. Samsung Medical Center, Sungkyunkwan University School of Medicine, 3. Daejeon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, 4. St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, 5. Korea University College of Medicine, Ansan, 6. Soonchunhyang University College of Medicine, Cheonan, 7. Seoul National University Bundang Hospital, Seongnam, 8. Korea University College of Medicine, Seoul, 9. Kyungpook National University School of Medicine, Daegu, 10. Keimyung University School of Medicine, Daegu, 11. Dongguk University Ilsan Hospital, Goyang, 12. Chosun University College of Medicine, Gwangju, 13. Kyung Hee University School of Medicine, Seoul, 14. Chung-Ang University Gwangmyeong Hospital, Gwangmyeong)
[PE-111]Mental Health and Quality of Life in Asian IBD Patients: A Cross-Sectional Study at a Tertiary Hospital in Singapore
*Yalan Hu1, Jacqueline Weiqian Lin1, Huiyu Lin2, Raymond Fueng Hin Liang2, Wee chian Lim2 (1. Department of Nursing, Tan Tock Seng Hospital, Singapore, 2. Department of Gastroenterology & Hepatology, Tan Tock Seng Hospital, Singapore)
[PE-112]Deep Learning-Driven Crypt-Fate Decision Model Predicts Mesenchymal-Like Transitions in Crohn’s Disease Using AI-Based Spatial Epigenetic Remodeling of Intestinal Stem Cell Niches
*Prihantini Prihantini1, Sahnaz Vivinda Putri2, Rini Winarti3, Elfiany Syafruddin4, Rifaldy Fajar1 (1. The Integrated Mathematical, Computational, and Data Science for BioMedicine Research Community Foundation, 2. International University Semen Indonesia, 3. Yogyakarta State University, 4. BLK Muhammadiyah University)
[PE-113]AI-Driven Multi-Omics Model Predicts Crypt Stem Cell Dysfunction and Fibrotic Remodeling in Crohn’s Disease
*Rifaldy Fajar1, Prihantini Prihantini1, Sahnaz Vivinda Putri2, Rini Winarti3, Elfiany Syafruddin4 (1. The Integrated Mathematical, Computational, and Data Science for BioMedicine Research Community Foundation, 2. International University Semen Indonesia, 3. Yogyakarta State University, 4. BLK Muhammadiyah University)
[PE-114]Multi-Resolution Deep Learning Identifies Hidden Epigenetic Predictors of Crohn’s Disease Penetrance and Treatment Resistance Using Single-Cell Multi-Omics Integration
*Sahnaz Vivinda Putri1, Rini Winarti2, Elfiany Syafruddin3, Prihantini Prihantini4, Rifaldy Fajar4 (1. International University Semen Indonesia, 2. Yogyakarta State University, 3. BLK Muhammadiyah University, 4. The Integrated Mathematical, Computational, and Data Science for BioMedicine Research Community Foundation)
[PE-115]Extremely high prevalence of multidrug-resistant organisms in gut flora of hospitalised patients with gastro-intestinal illness
*Himanshu Narang1, Purva Mathur2, Aparna Ningombam2, Arti Kapil3, Anoop Saraya1, Pramod Garg1, Shalimar .1, Deepak Gunjan1, Soumya Jagannath Mahapatra1, Anshuman Elhence1, Samagra Agarwal1, Manjeet Goyal1, Malambo Mubbunu1, Bipul Kumar1, Mukesh Singh1, Mahak Verma1, Radha Tiwari1, Govind Makharia1, Saurabh Kedia1, Vineet Ahuja1 (1. Department of Gastroenterology & Human Nutrition, All India Institute of Medical Sciences, New Delhi, 2. Department of Laboratory Medicine, Trauma Centre, All India Institute of Medical Sciences, New Delhi, 3. Department of Microbiology, All India Institute of Medical Sciences, New Delhi)
[PE-116]Deep Learning-Driven Multi-Omics Model for Personalized Anti-TNF Response Prediction in Crohn’s Disease
*Elfiany Syafruddin1, Sahnaz Vivinda Putri2, Rini Winarti3, Prihantini Prihantini4, Rifaldy Fajar4 (1. BLK Muhammadiyah University, 2. International University Semen Indonesia, 3. Yogyakarta State University, 4. The Integrated Mathematical, Computational, and Data Science for BioMedicine Research Community Foundation)
[PE-117]Deep Learning-Driven Predictive Model for Early Identification of Fibrostenotic Progression in Crohn’s Disease: Integrating Spatial Transcriptomics, Single-Cell Multi-Omics, and Temporal Graph Learning
*Rini Winarti1, Sahnaz Vivinda Putri2, Elfiany Syafruddin3, Prihantini Prihantini4, Rifaldy Fajar4 (1. Yogyakarta State University / Student, 2. International University Semen Indonesia, 3. BLK Muhammadiyah University, 4. The Integrated Mathematical, Computational, and Data Science for BioMedicine Research Community Foundation)
[PE-118]Effectiveness of switching from intravenous to subcutaneous infliximab in patients with Perianal Fistulizing Crohn’s Disease
*Sung Noh HONG1, Hyung Seok Kim1, Minjee Kim1, Ji Eun Kim1, Eun Ran Kim1, Dong Kyung Chang1, Young-Ho Kim1, Kyoung Doo Song1 (1. Samsung Medical Center, Sungkyunkwan University School of Medicine)
[PE-119]Tight endoscopic surveillance for the Treatment of Dysplasia in ulcerative colitis
*Akihito Tanaka1, Nobuhisa Maeda1, Haruka Yutsudo2, Satoshi Mori3, Yuga Komaki1, Shuji Kanmura1, Akio Ido1 (1. Kagoshima University Graduate School of Medical and Dental Sciences, Digestive and Lifestyle Diseases, 2. Kagoshima Kouseiren Hospital, Department of Gastroenterology, 3. Imamura general hospital, Department of Gastroenterology)
[PE-120]Evaluating the efficacy of tonsil-derived mesenchymal stem cells and intestinal stem cells- like cells in modulating fibrosis and inflammation in murine colitis models
*Ju Ran Byeon1, Eun Mi Song1, Yang Hee Joo1, A Reum Choe1, Yehyun Park1, Chung Hyun Tae1, Sung-Eun kim1, Ki-Nam Shim1, Sung-Ae Jung1 (1. Ewha Womans University College of Medicine, Department of Internal Medicine and Inflammatory Bowel Disease Center, Ewha Medical Research Institute, Seoul, Korea)
[PE-121]Factors associated with discontinuation of biologics or small molecules in patients with inflammatory bowel disease
*Ju Ran Byeon1, Yang Hee Joo1, A Reum Choe1, Yehyun Park1, Sung-Eun kim1, Sung-Ae Jung1, Eun Mi Song1 (1. Ewha Womans University College of Medicine, Department of Internal Medicine and Inflammatory Bowel Disease Center, Ewha Medical Research Institute, Seoul, Korea)
[PE-122]ABO blood type and clinical characteristics of patients with ulcerative colitis at the First Central hospital of Mongolia D.Ariunzul B.Tuvshintur O.Zurgaanjin B.Bat-Ulzii O. Bayarmaa 1 The First Central hospital of Mongolia 1
*Ariunzul Dashdondog1 (1. The first central hospital pf Mongolia)
[PE-123]Ustekinumab-Induced Hypophysitis in a Patient with Refractory Crohn’s Disease: A Rare Case of Secondary Adrenal Insufficiency
*Ban Hong Ang1, Ida Normiha1 (1. Universiti Malaya Medical Centre)
[PE-124]Clinical Feature Analysis of Inflammatory Bowel Disease Complicated with Primary Sclerosing Cholangitis
*Kexin Chen1,2,3, Jiaxin Li1,2,3, Fang Yin1,2,3, Yushan Wu1,2,3, Lili Li1,2,3, Hao Lin1,2,3, Jiangmei Pang1,2,3, Yongbin Jia2,3, Yan Li1,2,3, Hu Zhang1,2,3 (1. Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, China, 2. Centre for Inflammatory Bowel Disease, West China Hospital, Sichuan University, Chengdu, China, 3. Laboratory of Inflammatory Bowel Disease, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China)
[PE-125]Long-term Real-world Efficacy and Safety of Tofacitinib for Ulcerative Colitis: A Five-year Retrospective Study
*Dong Hoon Baek1, Seung Min Hong1, Geun Am Song1 (1. Pusan National University Hospital)
[PE-126]Mapping the Landscape of Endoscopic Balloon Dilation in IBD: A Bibliometric Perspective
*Zelin Yan1,2, Wenhang Xu1, Yihong Fan1, Yan Chen2 (1. Zhejiang Provincial Key Laboratory of Gastrointestinal Diseases Pathophysiology, Department of Gastroenterology, The First Affiliated Hospital of Zhejiang Chinese Medical University., 2. Center of Inflammatory Bowel Diseases, Department of Gastroenterology, The Second Affiliated Hospital, Zhejiang University School of Medicine.)
[PE-127]Microbiome Diversity and Taxonomic Differences in Quiescent Ulcerative Colitis: A Comparative Study of Proximal Extension
*Sung Hoon Jung1, Sang-Bum Kang1 (1. The Catholic University of Korea)
[PE-128]The Role of CALLY Index in Disease Assessment and Prognosis of Active Ulcerative Colitis
*Yingyu Chen1, Jiahui Zeng1, Yun Qiu1, Yao He1 (1. The First Affiliated Hospital, Sun Yat-sen University)
[PE-129]Beyond Convential therapy targeting multiple pathways: Combination Tofacitinib-Ustekinumab in Refractory Crohn's disease
*Bhaskar Kante1, Sreekanth Appasani1, Harshavardhan Reddy1, Venu Gongati1, Spoorthi Kolla1, Vishwanath Kamisetty1, Srinu Deshidi1, Harshavardhan Telaprolu1 (1. Krishna Institue of Medical Sciences , Hyderabad, Telangana, India)
[PE-130]EFFICACY AND SAFETY OF GUSELKUMAB FOR ULCERATIVE COLITIS THROUGH WEEK 92 OF THE QUASAR LONG-TERM EXTENSION STUDY
*TADAKAZU HISAMATSU1, Mary R. Lichtenstein2, Jessica R. Allegretti3, David T Rubin4, Brian G. Feagan5, Brian Bressler6, Julián Panés7, Waqqas Afif8, Mark A Samaan9, Byong Duk Ye10, Shadi Yarandi11, Matthew Germinaro11, Nicole Shipitofsky11, Ye Miao11, Pankaj Mistry11, Hongyan Zhang11, Axel Dignass12, Bruce E. Sands13, Laurent Peyrin- Biroulet14 (1. Kyorin University School of Medicine, Tokyo, Japan, 2. University of Pennsylvania, Philadelphia, PA, USA, 3. Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA, 4. University of Chicago Medicine Inflammatory Bowel Disease Centre, Chicago, IL, USA, 5. Western University, London, ON, Canada, 6. University of British Columbia, Vancouver, BC, Canada, 7. Hospital Clínic de Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain, 8. Division of Gastroenterology, McGill University Health Care, Montréal, Québec, CA, 9. Inflammatory Bowel Disease Unit, Guy’s and St Thomas’ NHS Foundation Trust, London, UK, 10. University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea, 11. Janssen Research & Development, LLC, Spring House, PA, USA, 12. Department of Medicine I, Agaplesion Markus Hospital, Goethe University, Frankfurt, Germany, 13. Icahn School of Medicine at Mount Sinai, New York, NY, USA, 14. University of Lorraine, Inserm, NGERE, F-54000 Nancy, France and Groupe Hospitalier Privé Ambroise Paré-Hartmann, Paris IBD Centre, 92200 Neuilly-sur-Seine, France)
[PE-131]Efficacy and safety of subcutaneous guselkumab induction therapy in patients with ulcerative colitis: Results through week 12 from the phase 3 ASTRO study
*TADAKAZU HISAMATSU1, Laurent Peyrin-Biroulet2, Jessica R. Allegretti3, Silvio Danese4, Matthew Germinaro5, Thomas Baker5, Yelina Alvarez5, Silke Jörgens5, Lingjing Jiang5, Hongyan Zhang5, David T. Rubin6, Millie Long7 (1. Kyorin University School of Medicine, Tokyo, Japan, 2. University of Lorraine, Inserm, NGERE, F-54000 Nancy, France and Groupe Hospitalier privé Ambroise Paré-Hartmann, Paris IBD Centre, 92200 Neuilly sur Seine, France, 3. Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA, 4. Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele and University Vita-Salute San Raffaele, Milan, Italy, 5. Janssen Research & Development, LLC, Spring House, PA, USA, 6. University of Chicago Medicine Inflammatory Bowel Disease Centre, Chicago, IL, USA, 7. Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA)
[PE-132]Impact of Small Area Level Deprivation on Colorectal Cancer
Survival: Findings from the Regional Cancer Registry in Korea
Seung Min Hong1, Ahreum Kim1, Changhoon Kim1, Seunghye Jang1, Dong Uk Kim2, *Dong Hoon Baek1, Seung Hun Lee1, Yu Hyeon Yi1, Heeseung Park1, Jonghyun Lee1, Tae In Kim1, Hyun Joo Lee1 (1. Pusan National University Hospital, 2. CHA University Gumi Medical Center)
[PE-133]Comparison of Clinical Outcomes Between Planned Piecemeal Endoscopic Mucosal Resection and Endoscopic Submucosal Dissection for Neoplasms Involving the Appendiceal Orifice and Lumen
Seung Min Hong1, *Dong Hoon Baek1, Geun Am Song1, Gwang Ha Kim1, Moon Won Lee1, Sungyong Han1, Bong Eun Lee1 (1. Department of Internal Medicine, Pusan National University School of Medicine, Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea)